“…Diacerein is one of the drugs, included in the disease-modifying osteoarthritis drug group (DMOADs), which aims to suppress the development of the disease rate, improving the structure and function of the cartilage and surrounding tissue (Sofia et al, 2018). Diacerein has a rhein structure, which is a molecule with anthraquinonic ring.…”